AMMD Inks Research Contract - Analyst Blog
18 May 2011 - 11:00PM
Zacks
Leading pelvic-health devices
provider American Medical Systems (AMMD) recently
signed a research grant contract for six sites to analyze safety,
anatomical and functional results of two alternative treatments for
vaginal prolapse. The Anterior Colporrhaphy is a technique that
utilizes traditional suture placation compared with the Elevate
Anterior and Apical Prolapse Repair System.
The Elevate system is an element of
American Medical’s composite portfolio of products intended to
treat women’s pelvic floor collapse and incontinence. Elevate is a
less invasive and thorough solution for treatment of apical and
anterior problems. The complete trans-vaginal methodology is
intended to reduce trauma to tissue by providing precise,
uncomplicated and safe apical mesh positioning in the sacrospinous
ligament and obturator internus muscle through one vaginal
incision. Elevate is the most popular vaginal mesh kit with over
35,000 patients treated since its launch in
2008.
Past studies of mesh reinforcement
for repairs have mainly concentrated on vaginal anatomy. The
purpose of the current study is to address lower urinary tract and
vaginal functions in addition to efficacy and safety. The
objective, after 12 months to 24 months of follow up, is to gather
evidence for the selection of the best surgical procedure for
patients facing transvaginal prolapse repair.
This study, involving a total of
214 patients, will be randomized, single blinded, and prospective,
and will be conducted at half a dozen participating centers. The
managing site will be the Mayo Clinic and it has selected six
independent implanting sites, five of which are located in the U.S.
and one in Germany.
American Medical is slated to be
acquired by specialty healthcare solutions company Endo
Pharmaceuticals (ENDP), in the third quarter of 2011.
Under the deal, announced in April 2011, Endo Pharmaceuticals will
buy American Medical for $2.9 billion (or $30.00 per share in
cash).
The consideration includes the
assumption of $312 million of debt. The deal has been approved by
the boards of both companies and is subject to the approval of
American Medical’s shareholders, antitrust clearance and attainment
of other closing conditions. The company will announce a special
shareholder meeting, in due course, to secure stockholder clearance
of the proposed deal. Currently, we have a Neutral rating on
American Medical.
AMER MED SYS (AMMD): Free Stock Analysis Report
ENDO PHARMACEUT (ENDP): Free Stock Analysis Report
Zacks Investment Research
American Medical Systems (NASDAQ:AMMD)
Historical Stock Chart
From May 2024 to Jun 2024
American Medical Systems (NASDAQ:AMMD)
Historical Stock Chart
From Jun 2023 to Jun 2024